Zhang Yifan, He Chenxin, Zhao Yusheng, Jiang Mingmin, Yao Jingchun, Cheng Guoliang, Niu Dejun, Zeng Zhen, Dai Ertong, Liu Ruiyan, Shang Guojiao, Qu Xiaohan, Kong Hui, Zhang Yue, Qu Huihua, Zhao Yan
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China; Senior Department of Burns and Plastic Surgery, the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100048, China.
Phytomedicine. 2025 Nov;147:157198. doi: 10.1016/j.phymed.2025.157198. Epub 2025 Aug 29.
Yuzhi Zhixue (YZZX) granules, a classic Chinese herbal remedy, have demonstrated efficacy in managing hemorrhagic and inflammatory conditions, and are clinically used to treat uterine bleeding. Building upon their documented clinical applications and phytochemical composition, we hypothesized that YZZX may also possess therapeutic potential against ulcerative colitis (UC). This research aimed to examine the immunomodulatory effects of YZZX granules on Th1/Th17-mediated immune reactions in a murine UC model induced by dextran sulfate sodium (DSS).
The major small-molecule constituents and macromolecular nano-components, specifically carbon dots (CDs), in YZZX were identified using UHPLC-QE-MS and other modern analytical techniques. UC was induced in mice via ad libitum access to a 2.5 % DSS solution, with YZZX administered orally. Anti-inflammatory effects were assessed by monitoring disease activity index (DAI) scores, body weight, colon length, ulcer area, and histopathological features. To uncover the mechanistic pathways of YZZX in UC treatment, transcriptomic sequencing, Flow cytometry, ELISA, RT-qPCR and Western blotting were conducted on colon tissue samples.
YZZX significantly mitigated body weight loss, reduced DAI scores, ameliorated histopathological damage, and prevented colon shortening in UC mice. It improved the intestinal barrier function by promoting the upregulation of mucin MUC-2 and tight junction proteins (e.g., claudin, occludin, and ZO-1). Additionally, YZZX restored immune balance by modulating Th17/Treg and Th1/Th2 cell responses through the normalization of cytokine secretion and transcription factor expression. Transcriptomic analysis revealed that YZZX modulates the immune-inflammatory responses in colitis primarily via the JAK/STAT signaling pathway. These findings were further validated by Western blotting and RT-qPCR, which showed that YZZX suppressed the activation of this pathway by downregulating phosphorylated JAK/STAT protein expression.
YZZX granules exert immunomodulatory effects primarily by rebalancing Th1/Th2 and Th17/Treg cell populations in the colon via inhibition of the JAK/STAT signaling pathway, thereby alleviating mucosal inflammation. This is the first study to systematically demonstrate the synergistic protective effects of both small-molecule compounds and carbon dot nano-components, derived from a traditional Chinese medicine formula in a DSS-induced murine model of UC.
禹志止血(YZZX)颗粒是一种经典的中药制剂,已证明在治疗出血性和炎症性疾病方面具有疗效,临床上用于治疗子宫出血。基于其已记录的临床应用和植物化学成分,我们推测YZZX可能也具有治疗溃疡性结肠炎(UC)的潜力。本研究旨在研究YZZX颗粒对葡聚糖硫酸钠(DSS)诱导的小鼠UC模型中Th1/Th17介导的免疫反应的免疫调节作用。
使用超高效液相色谱-四极杆飞行时间质谱(UHPLC-QE-MS)和其他现代分析技术鉴定YZZX中的主要小分子成分和大分子纳米成分,特别是碳点(CDs)。通过让小鼠自由饮用2.5%的DSS溶液诱导UC,口服给予YZZX。通过监测疾病活动指数(DAI)评分、体重、结肠长度、溃疡面积和组织病理学特征来评估抗炎作用。为了揭示YZZX在UC治疗中的作用机制途径,对结肠组织样本进行了转录组测序、流式细胞术、酶联免疫吸附测定(ELISA)、逆转录定量聚合酶链反应(RT-qPCR)和蛋白质免疫印迹法(Western blotting)。
YZZX显著减轻了UC小鼠的体重减轻,降低了DAI评分,改善了组织病理学损伤,并防止了结肠缩短。它通过促进粘蛋白MUC-2和紧密连接蛋白(如claudin、occludin和ZO-1)的上调来改善肠道屏障功能。此外,YZZX通过调节细胞因子分泌和转录因子表达的正常化来调节Th17/Treg和Th1/Th2细胞反应,从而恢复免疫平衡。转录组分析表明,YZZX主要通过JAK/STAT信号通路调节结肠炎中的免疫炎症反应。蛋白质免疫印迹法和RT-qPCR进一步验证了这些发现,结果显示YZZX通过下调磷酸化JAK/STAT蛋白表达来抑制该信号通路的激活。
YZZX颗粒主要通过抑制JAK/STAT信号通路来重新平衡结肠中的Th1/Th2和Th17/Treg细胞群,从而发挥免疫调节作用,减轻黏膜炎症。这是第一项系统证明源自中药配方的小分子化合物和碳点纳米成分在DSS诱导的小鼠UC模型中具有协同保护作用的研究。